Impact ledger
Spero Therapeutics Inc. (SPRO)
4 events mapped to this ticker since 2026-07-14.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-07-14 | wacc | Bullish | — | 0.70 |
| 2026-07-14 | interest_expense | Bullish | — | 0.70 |
| 2026-07-14 | net_debt | Bullish | — | 0.70 |
| 2026-07-14 | share_count | Bullish | — | 0.70 |
| 2026-07-14 | net_debt | Bullish | — | 0.70 |
| 2026-07-14 | revenue | Bullish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-14 | Event | Direct infusion of capital for operations and commercialization, reducing immediate financing risk. | Bullish | 1-3m | 0.90 |
| 2026-07-14 | Event | Direct financing for drug development, reducing immediate dilution risk and strengthening liquidity. | Bullish | 1-3m | 0.90 |
| 2026-07-14 | Event | Strategic acquisition of a new drug candidate (SP001/IBI355) expands pipeline and potential future revenue streams. The deal structure, involving an exclusive license, suggests a focus on development and commercialization outside of Greater China. | Bullish | 1-5y | 0.80 |
| 2026-07-14 | Event | Improved liquidity and reduced financing risk for clinical development programs. | Bullish | 1-3m | 0.80 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for SPRO, start a trial or view the SPRO entity page.